SK

Sarah Kutscher

IG Immatics Biotechnologies Gmbh: 11 patents #33 of 99Top 35%
📍 Rötteln, DE: #30 of 115 inventorsTop 30%
Overall (All Time): #444,452 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12121572 Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Anita Wiebe 2024-10-22
12097248 Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Anita Wiebe 2024-09-24
12076380 Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Anita Wiebe 2024-09-03
12070491 Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Anita Wiebe 2024-08-27
11786583 Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Anita Wiebe 2023-10-17
11779638 Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Anita Wiebe 2023-10-10
11679147 Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Anita Wiebe 2023-06-20
11672848 Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Anita Wiebe 2023-06-13
11576956 Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Anita Wiebe 2023-02-14
11559573 Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Anita Wiebe 2023-01-24
11406693 Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Anita Wiebe 2022-08-09